149 related articles for article (PubMed ID: 29090378)
1. Effect of Gastrogastric Fistula Closure in Type 2 Diabetes.
Meister KM; Schauer PR; Brethauer SA; Aminian A
Obes Surg; 2018 Apr; 28(4):1086-1090. PubMed ID: 29090378
[TBL] [Abstract][Full Text] [Related]
2. Metabolic Effect of Foregut Exclusion Demonstrated by the Impact of Gastrogastric Fistula on Recurrence of Diabetes.
Jirapinyo P; Thompson AC; Kröner PT; Chan WW; Thompson CC
J Am Coll Surg; 2018 Mar; 226(3):259-266.e1. PubMed ID: 29274838
[TBL] [Abstract][Full Text] [Related]
3. Effect of Roux-en-Y gastric bypass with different pouch size in Chinese T2DM patients with BMI 30-35 kg/m2.
Ren Y; Yang W; Yang J; Wang C
Obes Surg; 2015 Mar; 25(3):457-63. PubMed ID: 25236397
[TBL] [Abstract][Full Text] [Related]
4. Early results of Roux-en-Y gastric by-pass on regulation of diabetes type 2 in patients with BMI above and below 35 kg/m2.
Proczko-Markuszewska M; Stefaniak T; Kaska Ł; Sledziński Z
Pol Przegl Chir; 2011 Feb; 83(2):81-6. PubMed ID: 22166285
[TBL] [Abstract][Full Text] [Related]
5. Classification, surgical management and outcomes of patients with gastrogastric fistula after Roux-En-Y gastric bypass.
Ribeiro-Parenti L; De Courville G; Daikha A; Arapis K; Chosidow D; Marmuse JP
Surg Obes Relat Dis; 2017 Feb; 13(2):243-248. PubMed ID: 27889483
[TBL] [Abstract][Full Text] [Related]
6. Surgical management of gastrogastric fistula.
Corcelles R; Jamal MH; Daigle CR; Rogula T; Brethauer SA; Schauer PR
Surg Obes Relat Dis; 2015; 11(6):1227-32. PubMed ID: 26003896
[TBL] [Abstract][Full Text] [Related]
7. Management of gastrogastric fistulas after divided Roux-en-Y gastric bypass surgery for morbid obesity: analysis of 1,292 consecutive patients and review of literature.
Carrodeguas L; Szomstein S; Soto F; Whipple O; Simpfendorfer C; Gonzalvo JP; Villares A; Zundel N; Rosenthal R
Surg Obes Relat Dis; 2005; 1(5):467-74. PubMed ID: 16925272
[TBL] [Abstract][Full Text] [Related]
8. Relationships between type 2 diabetes remission after gastric bypass and different weight loss metrics: arguments against excess weight loss in metabolic surgery.
van de Laar AW; de Brauw LM; Meesters EW
Surg Obes Relat Dis; 2016 Feb; 12(2):274-82. PubMed ID: 26476492
[TBL] [Abstract][Full Text] [Related]
9. Laparoscopic remnant gastrectomy: a novel approach to gastrogastric fistula after Roux-en-Y gastric bypass for morbid obesity.
Cho M; Kaidar-Person O; Szomstein S; Rosenthal RJ
J Am Coll Surg; 2007 Apr; 204(4):617-24. PubMed ID: 17382221
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic remnant gastrectomy as a novel approach for treatment of gastrogastric fistula.
Salimath J; Rosenthal RJ; Szomstein S
Surg Endosc; 2009 Nov; 23(11):2591-5. PubMed ID: 19462204
[TBL] [Abstract][Full Text] [Related]
11. Effect of Roux-en-Y Gastric Bypass on Remission of T2D: Medium-Term Follow-up in Chinese Patients with Different BMI Obesity Class.
Zhang H; Han X; Yu H; Di J; Zhang P; Jia W
Obes Surg; 2017 Jan; 27(1):134-142. PubMed ID: 27312346
[TBL] [Abstract][Full Text] [Related]
12. Effects of gastrogastric fistula repair on weight loss and gut hormone levels.
O'Brien CS; Wang G; McGinty J; Agénor KK; Dutia R; Colarusso A; Park K; Koshy N; Laferrère B
Obes Surg; 2013 Aug; 23(8):1294-301. PubMed ID: 23549962
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of laparoscopic sleeve gastrectomy versus roux-en-Y gastric bypass for the treatment of Chinese type 2 diabetes mellitus patients with body mass index 28-35 kg/m(2).
Yang J; Wang C; Cao G; Yang W; Yu S; Zhai H; Pan Y
BMC Surg; 2015 Jul; 15():88. PubMed ID: 26198306
[TBL] [Abstract][Full Text] [Related]
14. Case-matched outcomes in bariatric surgery for treatment of type 2 diabetes in the morbidly obese patient.
Dorman RB; Serrot FJ; Miller CJ; Slusarek BM; Sampson BK; Buchwald H; Leslie DB; Bantle JP; Ikramuddin S
Ann Surg; 2012 Feb; 255(2):287-93. PubMed ID: 21975321
[TBL] [Abstract][Full Text] [Related]
15. Management of gastrogastric fistula after laparoscopic Roux-en-Y gastric bypass.
Gumbs AA; Duffy AJ; Bell RL
Surg Obes Relat Dis; 2006; 2(2):117-21. PubMed ID: 16925334
[TBL] [Abstract][Full Text] [Related]
16. Outcomes in glycemic control in the intermediate follow-up of Roux-en-Y gastric bypass: a Brazilian cohort study.
Beleigoli AM; Coelho AL; Diniz MT; Lages Savassi-Rocha A; Diniz Mde F
Surg Obes Relat Dis; 2014; 10(6):1022-7. PubMed ID: 25445150
[TBL] [Abstract][Full Text] [Related]
17. "Dual-remission" after Roux-en-Y gastric bypass surgery: Glycemic variability cannot always be improved in Chinese obese patients with type 2 diabetes.
Yu H; Zhou J; Bao Y; Pin Zhang ; Lu W; Jia W
Surg Obes Relat Dis; 2016 Aug; 12(7):1312-1319. PubMed ID: 26823091
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of laparoscopic Roux-en-Y gastric bypass on diabetes mellitus, hypertension and dyslipidaemia in morbidly obese patients.
Dogan K; Betzel B; Homan J; Aarts EO; Ploeger N; de Boer H; Aufenacker TJ; van Laarhoven CJ; Janssen IM; Berends FJ
Obes Surg; 2014 Nov; 24(11):1835-42. PubMed ID: 25027982
[TBL] [Abstract][Full Text] [Related]
19. Metabolic intestinal bypass surgery for type 2 diabetes in patients with a BMI <35 kg/m2: comparative analysis of 16 patients undergoing either BPD, BPD-DS, or RYGB.
Frenken M; Cho EY
Obes Facts; 2011; 4 Suppl 1(Suppl 1):13-7. PubMed ID: 22027284
[TBL] [Abstract][Full Text] [Related]
20. Type 2 diabetes after gastric bypass: remission in five models using HbA1c, fasting blood glucose, and medication status.
Blackstone R; Bunt JC; Cortés MC; Sugerman HJ
Surg Obes Relat Dis; 2012; 8(5):548-55. PubMed ID: 22721581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
